Disease Severity Treatment Outcomes in Vitiligo: A Systematic Review of Randomized Controlled Trials

Abstract

Keywords

vitiligo targeted therapy treatment systematic review

Get full access to this article

View all access options for this article.

References

Mukhatayev

Le Poole

IC.

Vitiligo: advances in pathophysiology research and treatment development. Trends Mol Med. 2024;30(9):844-862. doi:10.1016/j.molmed.2024.04.009

Faraj

Kemp

Gawkrodger

DJ.

Patho-immunological mechanisms of vitiligo: the role of the innate and adaptive immunities and environmental stress factors. Clin Exp Immunol. 2022;207(1):27-43. doi:10.1093/cei/uxab002

Gholijani

Yazdani

Dastgheib

Predominant role of innate pro-inflammatory cytokines in vitiligo disease. Arch Dermatol Res. 2020;312(2):123-131. doi:10.1007/s00403-019-01996-9

Liu

Gao

Janus kinase inhibitors in the treatment of vitiligo: a review. Front Immunol. 2021;12:790125. doi:10.3389/fimmu.2021.790125

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.01 MB

0.07 MB

0.02 MB

0.03 MB